TD Waterhouse Canada Inc. Has $67.76 Million Stock Holdings in Stryker Corporation $SYK

TD Waterhouse Canada Inc. increased its stake in shares of Stryker Corporation (NYSE:SYK) by 6.0% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 170,867 shares of the medical technology company’s stock after acquiring an additional 9,640 shares during the period. TD Waterhouse Canada Inc.’s holdings in Stryker were worth $67,759,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Stryker in the 2nd quarter worth approximately $26,000. Sachetta LLC lifted its position in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares during the period. Ridgewood Investments LLC boosted its stake in Stryker by 48.4% in the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after acquiring an additional 30 shares during the last quarter. Ransom Advisory Ltd bought a new position in shares of Stryker in the 1st quarter worth $37,000. Finally, MTM Investment Management LLC acquired a new position in Stryker in the second quarter valued at about $38,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CAO William E. Berry, Jr. sold 1,953 shares of Stryker stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $365.49, for a total value of $713,801.97. Following the sale, the chief accounting officer owned 2,833 shares of the company’s stock, valued at approximately $1,035,433.17. This trade represents a 40.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Viju Menon sold 500 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares in the company, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 522,453 shares of company stock worth $185,516,867. Corporate insiders own 5.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on SYK shares. Redburn Partners set a $420.00 price target on Stryker in a research note on Thursday, September 18th. Wells Fargo & Company upped their target price on shares of Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research note on Friday, November 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a report on Thursday, November 13th. Truist Financial boosted their price target on shares of Stryker from $392.00 to $400.00 and gave the company a “hold” rating in a report on Friday, November 14th. Finally, Needham & Company LLC restated a “buy” rating and issued a $448.00 price objective on shares of Stryker in a research report on Friday. Thirteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $434.37.

Stryker Stock Performance

Shares of SYK opened at $359.53 on Wednesday. The firm has a market cap of $137.49 billion, a P/E ratio of 47.62, a PEG ratio of 2.66 and a beta of 0.94. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $406.19. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The firm’s 50 day moving average price is $370.62 and its two-hundred day moving average price is $381.03.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, October 30th. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.06. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. During the same quarter in the prior year, the firm earned $2.87 earnings per share. The firm’s revenue was up 10.2% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.